Kadimastem Ltd
KDST
Rang in aandelen
#40943
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Aandeelprijs
$12.16
Laatst gesynchroniseerd: 2025-10-30
Marktkapitalisatie
$50.98K
Verandering (1 dag)
-0.10%
Verandering (1 jaar)
69.56%
Land
IL
Handel Kadimastem Ltd (KDST)
Categorie
Healthcare
Koersgeschiedenis voor Kadimastem Ltd (KDST)
Hoogste slotkoers: $3.43 op 2025-12-01
Laagste slotkoers: $8.68 op 2021-01-01
Laagste slotkoers: $8.68 op 2021-01-01
Koersgeschiedenis van Kadimastem Ltd van 2021 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 27.09% |
| 2025 | -62.21% |
| 2024 | -1.52% |
| 2023 | 0.00% |
| 2022 | -67.49% |
| 2021 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
